YK-11: Difference between revisions
CSV import |
CSV import |
||
| Line 1: | Line 1: | ||
{{DISPLAYTITLE:YK-11}} | |||
== Overview == | == Overview == | ||
[[File:YK-11.svg|thumb|right|Chemical structure of YK-11]] | |||
'''YK-11''' is a synthetic [[steroid]]al [[Selective Androgen Receptor Modulator|selective androgen receptor modulator]] (SARM) that has been studied for its potential effects on muscle growth and bone health. It is known for its unique ability to act as a partial agonist of the androgen receptor, which distinguishes it from other SARMs. | |||
[[ | == Mechanism of Action == | ||
YK-11 binds to the [[androgen receptor]] (AR) in a manner similar to other SARMs, but it also induces the expression of [[follistatin]], a protein that inhibits [[myostatin]]. Myostatin is a negative regulator of muscle growth, and by inhibiting it, YK-11 may promote increased muscle mass. This dual action makes YK-11 a compound of interest in the field of muscle wasting and osteoporosis research. | |||
== Potential Benefits == | |||
The potential benefits of YK-11 include: | |||
* '''Muscle Growth''': By inhibiting myostatin, YK-11 may enhance muscle hypertrophy and strength. | |||
* '''Bone Health''': YK-11 may contribute to bone density improvement, which is beneficial in conditions like [[osteoporosis]]. | |||
== | == Side Effects == | ||
As with many experimental compounds, the side effects of YK-11 are not fully understood. Potential side effects may include: | |||
* '''Hormonal Imbalance''': As a steroidal SARM, YK-11 may affect endogenous hormone levels, potentially leading to [[testosterone]] suppression. | |||
* '''Liver Toxicity''': There is a concern about liver toxicity with prolonged use, as with many oral steroids. | |||
=== | == Research and Development == | ||
Research on YK-11 is still in the early stages, with most studies being conducted in vitro or in animal models. Human clinical trials are necessary to fully understand its efficacy and safety profile. | |||
== Legal Status == | |||
YK-11 is not approved for human use by any major health regulatory body, such as the [[Food and Drug Administration|FDA]] or the [[European Medicines Agency|EMA]]. It is often sold as a research chemical, and its use in sports is prohibited by the [[World Anti-Doping Agency|WADA]]. | |||
== | == Related Pages == | ||
* [[Selective Androgen Receptor Modulator]] | |||
* [[Androgen Receptor]] | |||
* [[Myostatin]] | |||
* [[Follistatin]] | |||
* [[Osteoporosis]] | |||
[[Category:Selective Androgen Receptor Modulators]] | |||
[[Category:Steroids]] | |||
[[Category: | |||
[[Category: | |||
Latest revision as of 03:25, 13 February 2025
Overview[edit]

YK-11 is a synthetic steroidal selective androgen receptor modulator (SARM) that has been studied for its potential effects on muscle growth and bone health. It is known for its unique ability to act as a partial agonist of the androgen receptor, which distinguishes it from other SARMs.
Mechanism of Action[edit]
YK-11 binds to the androgen receptor (AR) in a manner similar to other SARMs, but it also induces the expression of follistatin, a protein that inhibits myostatin. Myostatin is a negative regulator of muscle growth, and by inhibiting it, YK-11 may promote increased muscle mass. This dual action makes YK-11 a compound of interest in the field of muscle wasting and osteoporosis research.
Potential Benefits[edit]
The potential benefits of YK-11 include:
- Muscle Growth: By inhibiting myostatin, YK-11 may enhance muscle hypertrophy and strength.
- Bone Health: YK-11 may contribute to bone density improvement, which is beneficial in conditions like osteoporosis.
Side Effects[edit]
As with many experimental compounds, the side effects of YK-11 are not fully understood. Potential side effects may include:
- Hormonal Imbalance: As a steroidal SARM, YK-11 may affect endogenous hormone levels, potentially leading to testosterone suppression.
- Liver Toxicity: There is a concern about liver toxicity with prolonged use, as with many oral steroids.
Research and Development[edit]
Research on YK-11 is still in the early stages, with most studies being conducted in vitro or in animal models. Human clinical trials are necessary to fully understand its efficacy and safety profile.
Legal Status[edit]
YK-11 is not approved for human use by any major health regulatory body, such as the FDA or the EMA. It is often sold as a research chemical, and its use in sports is prohibited by the WADA.